TriNetX announced today it has entered into an agreement with Takeda Pharmaceutical Company Limited (“Takeda”) to unlock the value of real-world data (RWD) and accelerate the delivery of transformative therapies to patients.
Italy’s Ospedale San Raffaele Joins the TriNetX Network to Expand its Leadership Position in Gene Therapy Research
TriNetX announces that Ospedale San Raffaele (OSR), Italy’s leading biomedical research institute and the country’s representative in the European University Hospital Alliance, has joined the TriNetX network to increase its commitment to clinical trial research and to build on its growing position as a leader in the field of gene therapy for rare diseases.
Plexus Research Joins the TriNetX Network to Increase Access to Industry-Sponsored Clinical Trials in South Australia
Plexus Research is a site management organization that operates the largest clinical trial network in South Australia with 10 clinics, 40 general practitioners (GPs) as investigators, and a database of 100,000 patients.
Hospital Alemão Oswaldo Cruz Joins the TriNetX Network to Expand Clinical Research Capabilities in Brazil and Latin America
Hospital Alemão Oswaldo Cruz, one of the largest hospital centers in Latin America, has announced a partnership with TriNetX to join the global health research network.
Ian Read, former Pfizer CEO & Chairman, named board chairman
TriNetX Expands the Breadth and Depth of its Global Research Network and Real-World Data Set Adding COVID-19 Vaccination Data to Longitudinal Patient Histories
TriNetX today announced that COVID-19 vaccination data is now available within the TriNetX platform and real-world data (RWD) set for clinical and observational research.